Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey
Amanda F
AF
Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, Michigan, USA.
Freed
Gary L
GL
D000293:Adolescent; D000328:Adult; D003362:Cost-Benefit Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D007115:Immunization Schedule; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000494:pharmacology; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination / Q000379:methods
D053918:Papillomavirus Vaccines